Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 18-28, January 2012

What We Have Learned: The Impact of Quality From a Clinical Trials Perspective

  • Thomas J. FitzGerald, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to T.J. FitzGerald, MD, Director, Quality Assurance Review Center, 640 George Washington Highway, Suite 201, Lincoln, RI 02865

Department of Radiation Oncology, UMass Memorial Healthcare, University of Massachusetts Medical School, Worcester, MA; and Quality Assurance Review Center, Lincoln, RI

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by NIH/NCI CA 29511 (Quality Assurance Review Center).

PII: S1053-4296(11)00095-6

doi:10.1016/j.semradonc.2011.09.004

Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 18-28, January 2012

Article Tools

* Image Usage & Resolution